# Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive Medication

> **NCT04798625** · — · ACTIVE_NOT_RECRUITING · sponsor: **Diakonhjemmet Hospital** · enrollment: 2300 (actual)

## Conditions studied

- Rheumatoid Arthritis
- Psoriatic Arthritis
- Spondyloarthritis
- Crohn Disease
- Ulcerative Colitis
- Autoimmune Hepatitis
- Liver Transplant; Complications

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04798625
- **Lead sponsor:** Diakonhjemmet Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-02-15
- **Primary completion:** 2026-02-15
- **Final completion:** 2027-02-15
- **Target enrollment:** 2300 (ACTUAL)
- **Last updated:** 2024-02-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04798625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04798625, "Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive Medication". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04798625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*